Source: Sabra Health Care REIT's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 03, 2026
Revenue, net income & free cash flow
Income statement
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$260.53M
$26.43M
$70.14M
$128.06M
$156.04M
$155.51M
$186.67M
$236.15M
$284.58M
$356.88M
Interest expense
$64.87M
$88.44M
$147.11M
$126.61M
$100.42M
$98.63M
$105.47M
$112.96M
$115.27M
$112.49M
Pre-tax income
$71.25M
$159.02M
$287.56M
$79.22M
$155.73M
$80.67M
$21.67M
$18.66M
$128.11M
$153.42M
Income tax
$1.05M
$651.00K
$3.01M
$3.40M
$710.00K
$1.84M
$1.24M
$2.00M
$1.00M
$1.84M
Net income
$70.28M
$158.38M
$279.08M
$69.00M
$138.42M
-$113.26M
-$77.61M
$13.76M
$126.71M
$155.61M
EPS (basic)
$0.92
$1.40
$1.51
$0.37
$0.67
$-0.52
$-0.34
$0.06
$0.54
$0.64
EPS (diluted)
$0.92
$1.40
$1.51
$0.37
$0.67
$-0.52
$-0.34
$0.06
$0.54
$0.64
Diluted shares
65.52M
105.84M
178.72M
188.13M
207.25M
219.07M
230.95M
232.79M
236.05M
244.50M
Net margin
27.0%
599.3%
397.9%
53.9%
88.7%
-72.8%
-41.6%
5.8%
44.5%
43.6%
Balance sheet
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash & equivalents
$25.66M
$518.63M
$50.23M
$39.10M
$59.08M
$112.00M
$49.31M
$41.28M
$60.47M
$71.54M
Total assets
$2.27B
$7.03B
$6.67B
$6.07B
$5.99B
$5.97B
$5.75B
$5.39B
$5.30B
$5.49B
Long-term debt
$1.21B
$3.39B
$3.23B
$2.40B
$2.37B
$2.39B
$2.51B
$2.41B
$2.42B
$2.53B
Total debt
$1.21B
$3.39B
$3.23B
$2.40B
$2.37B
$2.39B
$2.51B
$2.41B
$2.42B
$2.53B
Total liabilities
$1.25B
$3.60B
$3.41B
$2.58B
$2.58B
$2.59B
$2.69B
$2.58B
$2.56B
$2.67B
Shareholders' equity
$1.02B
$3.43B
$3.25B
$3.49B
$3.41B
$3.38B
$3.06B
$2.80B
$2.74B
$2.82B
Cash flow
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Operating cash flow
$175.93M
$135.79M
$360.59M
$372.48M
$354.85M
$356.39M
$315.73M
$300.57M
$310.54M
$348.61M
Free cash flow
$175.93M
$135.79M
$360.59M
$372.48M
$354.85M
$356.39M
$315.73M
$300.57M
$310.54M
$348.61M
Investing cash flow
$142.36M
-$182.56M
-$258.49M
$262.84M
-$136.45M
-$336.20M
-$216.25M
$103.13M
-$109.00M
-$377.96M
Financing cash flow
-$300.90M
$598.82M
-$629.34M
-$646.18M
-$202.11M
$30.14M
-$161.71M
-$410.30M
-$181.56M
$40.76M
Dividends paid
$119.26M
$182.09M
$325.22M
$335.44M
$278.30M
$262.92M
$277.16M
$277.45M
$280.15M
$289.50M
Stock-based compensation
$7.50M
$8.36M
$7.65M
$9.82M
$7.91M
$7.91M
$7.45M
$7.92M
$8.99M
$11.36M
Depreciation & amortization
$68.47M
$113.88M
$191.38M
$181.55M
$176.74M
$178.99M
$187.78M
$183.09M
$169.62M
$187.00M
Income statement
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
$61.26M
$66.03M
$67.94M
$73.75M
$76.86M
$77.45M
$78.98M
$92.02M
$108.43M
$116.69M
$128.80M
$143.16M
Interest expense
$27.94M
$28.41M
$29.31M
$29.47M
$28.08M
$27.10M
$27.55M
$28.90M
$28.94M
$28.41M
$29.78M
$29.16M
Pre-tax income
$18.41M
$27.30M
$24.33M
$29.31M
$47.17M
$40.50M
$65.21M
$21.73M
$25.99M
$39.43M
-$26.79M
$26.40M
Income tax
$493.00K
$453.00K
$437.00K
-$265.00K
$380.00K
$413.00K
$497.00K
$436.00K
$491.00K
$526.00K
$678.00K
$71.00K
Net income
$17.16M
$26.25M
$23.98M
$29.79M
$46.70M
$40.30M
$65.54M
$22.54M
$27.23M
$40.88M
-$25.20M
$28.61M
EPS (basic)
$0.07
$0.11
$0.10
$0.13
$0.20
$0.17
$0.28
$0.09
$0.10
$0.16
$-0.10
$0.11
EPS (diluted)
$0.07
$0.11
$0.10
$0.13
$0.20
$0.17
$0.27
$0.09
$0.11
$0.16
$-0.10
$0.11
Diluted shares
1.60M
233.37M
233.75M
237.04M
1.27M
240.30M
240.93M
243.56M
2.90M
255.97M
252.27M
259.82M
Net margin
28.0%
39.8%
35.3%
40.4%
60.7%
52.0%
83.0%
24.5%
25.1%
35.0%
-19.6%
20.0%
Balance sheet
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Cash & equivalents
$41.28M
$59.93M
$36.40M
$63.00M
$60.47M
$22.65M
$95.17M
$200.60M
$71.54M
$116.53M
$231.58M
$36.24M
Total assets
$5.39B
$5.37B
$5.35B
$5.37B
$5.30B
$5.23B
$5.33B
$5.56B
$5.49B
$5.59B
$5.51B
$5.43B
Long-term debt
$2.41B
$2.46B
$2.45B
$2.47B
$2.42B
$2.39B
$2.48B
$2.59B
$2.53B
$2.67B
$2.63B
$2.44B
Total debt
$2.41B
$2.46B
$2.45B
$2.47B
$2.42B
$2.39B
$2.48B
$2.59B
$2.53B
$2.67B
$2.63B
$2.44B
Total liabilities
$2.58B
$2.61B
$2.59B
$2.62B
$2.56B
$2.53B
$2.62B
$2.74B
$2.67B
$2.80B
$2.76B
$2.59B
Shareholders' equity
$2.80B
$2.77B
$2.76B
$2.74B
$2.74B
$2.70B
$2.71B
$2.82B
$2.82B
$2.79B
$2.75B
$2.84B
Cash flow
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Operating cash flow
$78.74M
$52.80M
$80.13M
$97.65M
$79.97M
$80.26M
$80.96M
$99.96M
$87.43M
$98.36M
$85.82M
$128.97M
Free cash flow
$78.74M
$52.80M
$80.13M
$97.65M
$79.97M
$80.26M
$80.96M
$99.96M
$87.43M
$98.36M
$85.82M
$128.97M
Investing cash flow
-$61.78M
-$13.22M
-$57.31M
-$57.03M
$18.56M
-$16.44M
-$45.13M
-$199.84M
-$116.55M
-$105.09M
$86.50M
-$171.85M
Financing cash flow
-$9.36M
-$20.23M
-$46.41M
-$13.96M
-$100.96M
-$101.24M
$36.73M
$206.17M
-$100.89M
$52.10M
-$57.36M
-$152.25M
Dividends paid
$69.37M
$69.44M
$69.45M
$70.28M
$70.98M
$71.37M
$71.38M
$71.94M
$74.81M
$75.66M
$75.66M
$76.64M
Stock-based compensation
$2.45M
$2.52M
$1.34M
$2.59M
$2.54M
$2.71M
$2.70M
$2.88M
$3.07M
$3.10M
$4.09M
$3.92M
Depreciation & amortization
$42.88M
$42.91M
$41.68M
$42.72M
$42.31M
$43.49M
$43.59M
$48.51M
$51.41M
$53.13M
$56.38M
$64.78M
Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.